Tues., June 21st, 2022
Tassos Gianakakos - CEO, MyoKardia
---Please join us as Tassos discusses his journey from conception to acquisition. MyoKardia was acquired in 2020 by Bristol Myers Squibb for $13.1 Billion in Cash.
Return to AZBio.org
"AZBio" is a 501(c)6 non-profit organization
107 S. Southgate Drive, Chandler, AZ 85226
Copyright 2016: AZBio, the Arizona Bioindustry Association, Inc.